Zobrazeno 1 - 10
of 3 484
pro vyhledávání: '"Choo QL"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Patrizia Farci
Publikováno v:
Journal of Hepatology. 36:582-585
A random-primed complementary DNA library was constructed from plasme containing the uncharacterized non-A, non-B hepatitis (NANBH) agent and screend with serum from a patient diagnosed with NANBH. A complementary DNA clone was isolated that was show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba36c113a73c7dd6efc49157c793bd2f
https://doi.org/10.1016/s0168-8278(02)00051-x
https://doi.org/10.1016/s0168-8278(02)00051-x
Autor:
Li X; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China; Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou 510445, China., Pang PS; Nansha Biologics (Hong Kong) Limited, Avalon BioMedical (Management) Limited, Unit 1511-1513 & 1515, Level 15, Tower II, Grand Central Plaza, 138 Shatin Rural Committee Road, Shatin, NT, Hong Kong., Zhang S; KG Pharma Limited, Foshan 528000, China., Ru L; Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou 510445, China., Yuan Z; Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou 510445, China., Liu R; Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou 510445, China., Choo QL; Nansha Biologics (Hong Kong) Limited, Avalon BioMedical (Management) Limited, Unit 1511-1513 & 1515, Level 15, Tower II, Grand Central Plaza, 138 Shatin Rural Committee Road, Shatin, NT, Hong Kong., Wang Q; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China; Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou 510445, China., Song J; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China., Xu Q; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China., Zhang K; KG Pharma Limited, Foshan 528000, China., Yu KM; Nansha Biologics (Hong Kong) Limited, Avalon BioMedical (Management) Limited, Unit 1511-1513 & 1515, Level 15, Tower II, Grand Central Plaza, 138 Shatin Rural Committee Road, Shatin, NT, Hong Kong. Electronic address: kyu@nansha-biologics.com., Xu Z; Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou 510445, China. Electronic address: xzy080@163.com.
Publikováno v:
Life sciences [Life Sci] 2020 Oct 15; Vol. 259, pp. 118244. Date of Electronic Publication: 2020 Aug 11.
Autor:
Sohal, Aalam1 (AUTHOR) aalamsohal@gmail.com, Singh, Carol2 (AUTHOR) singhcarol04@gmail.com, Bhalla, Akshita3 (AUTHOR) akshitabhalla11@gmail.com, Kalsi, Harsimran4 (AUTHOR) simrankalsi407@gmail.com, Roytman, Marina5 (AUTHOR) marina.roytman@ucsf.edu
Publikováno v:
Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 18, p5536. 24p.
Autor:
Toyodome, Ai1 (AUTHOR), Mawatari, Seiichi1 (AUTHOR) mawatari@m2.kufm.kagoshima-u.ac.jp, Eguchi, Hiromi1 (AUTHOR), Takeda, Midori2 (AUTHOR), Kumagai, Kotaro1 (AUTHOR), Taniyama, Ohki1 (AUTHOR), Ijuin, Sho1 (AUTHOR), Sakae, Haruka1 (AUTHOR), Tabu, Kazuaki1 (AUTHOR), Oda, Kohei1 (AUTHOR), Ikeda, Masanori2 (AUTHOR), Ido, Akio1 (AUTHOR)
Publikováno v:
Scientific Reports. 7/16/2024, Vol. 14 Issue 1, p1-9. 9p.
Autor:
Salem, Dalia Diaa ElDine1 (AUTHOR) daliadiaa@med.asu.edu.eg, ElSayed, Heba-TAllah Nader2 (AUTHOR)
Publikováno v:
Egyptian Liver Journal. 7/5/2024, Vol. 14 Issue 1, p1-6. 6p.
Autor:
Yu KM; Nansha Biologics (Hong Kong) Ltd, Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong. Electronic address: kyu@nansha-biologics.com., Yiu-Nam Lau J; Nansha Biologics (Hong Kong) Ltd, Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong., Fok M; Nansha Biologics (Hong Kong) Ltd, Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong; Faculty of Health Sciences, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau., Yeung YK; Nansha Biologics (Hong Kong) Ltd, Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong., Fok SP; Nansha Biologics (Hong Kong) Ltd, Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong., Hu TL; Biomedical Technology and Device Research Labs, Industrial Technology and Research Institute, 195, Sec. 4, Chung Hsing Rd., Chutung, Hsinchu, Taiwan 31040., Tsai YJ; Biomedical Technology and Device Research Labs, Industrial Technology and Research Institute, 195, Sec. 4, Chung Hsing Rd., Chutung, Hsinchu, Taiwan 31040., Choo QL; Nansha Biologics (Hong Kong) Ltd, Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2018 Nov; Vol. 107 (11), pp. 2755-2763. Date of Electronic Publication: 2018 Jul 10.
Efficient expression and isolation of recombinant human interleukin-11 (rhIL-11) in Pichia pastoris.
Autor:
Yu KM; Nansha Biologics (Hong Kong) Limited, Unit 608-613, IC Development Centre, No.6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong Special Administrative Region, China; Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong. Electronic address: kyu@nansha-biologics.com., Yiu-Nam Lau J; Nansha Biologics (Hong Kong) Limited, Unit 608-613, IC Development Centre, No.6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong Special Administrative Region, China., Fok M; Nansha Biologics (Hong Kong) Limited, Unit 608-613, IC Development Centre, No.6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong Special Administrative Region, China., Yeung YK; Nansha Biologics (Hong Kong) Limited, Unit 608-613, IC Development Centre, No.6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong Special Administrative Region, China., Fok SP; Nansha Biologics (Hong Kong) Limited, Unit 608-613, IC Development Centre, No.6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong Special Administrative Region, China., Shek F; Nansha Biologics (Hong Kong) Limited, Unit 608-613, IC Development Centre, No.6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong Special Administrative Region, China., Wong WT; Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong., Choo QL; Nansha Biologics (Hong Kong) Limited, Unit 608-613, IC Development Centre, No.6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong Special Administrative Region, China.
Publikováno v:
Protein expression and purification [Protein Expr Purif] 2018 Jun; Vol. 146, pp. 69-77. Date of Electronic Publication: 2018 Feb 03.
Preclinical evaluation of the mono-PEGylated recombinant human interleukin-11 in cynomolgus monkeys.
Autor:
Yu KM; Nansha Biologics (Hong Kong) Ltd., Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong, China; Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong. Electronic address: kyu@nansha-biologics.com., Lau JY; Nansha Biologics (Hong Kong) Ltd., Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong, China., Fok M; Nansha Biologics (Hong Kong) Ltd., Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong, China., Yeung YK; Nansha Biologics (Hong Kong) Ltd., Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong, China., Fok SP; Nansha Biologics (Hong Kong) Ltd., Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong, China., Zhang S; KG Pharma Limited, Wuhua Road, Zhangcha Subdistrict, Foshan 528000, China., Ye P; KG Pharma Limited, Wuhua Road, Zhangcha Subdistrict, Foshan 528000, China., Zhang K; KG Pharma Limited, Wuhua Road, Zhangcha Subdistrict, Foshan 528000, China., Li X; New South Center for Safety Evaluation of Drugs, 436, Chentai Road, Baiyun District, Guangzhou, China., Li J; New South Center for Safety Evaluation of Drugs, 436, Chentai Road, Baiyun District, Guangzhou, China., Xu Q; New South Center for Safety Evaluation of Drugs, 436, Chentai Road, Baiyun District, Guangzhou, China; Institute of Tropical Medicine, Guangzhou University of Chinese Medicine, China., Wong WT; Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong., Choo QL; Nansha Biologics (Hong Kong) Ltd., Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong, China.
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2018 Mar 01; Vol. 342, pp. 39-49. Date of Electronic Publication: 2018 Feb 02.
Autor:
Wen, Kang1 (AUTHOR), Chen, Xin1 (AUTHOR), Gu, Jingyao1 (AUTHOR), Chen, Zhenyao2,3 (AUTHOR) czy_556@163.com, Wang, Zhaoxia1 (AUTHOR) zhaoxiawang66@126.com
Publikováno v:
Journal of Biomedical Science. 6/14/2024, Vol. 31 Issue 1, p1-17. 17p.